IPSEN PHARMA
société par actions simplifiée (SAS) · PARIS, France · LEI 96950004ZQHLJ6V8PJ87
LEI active
Summary
IPSEN PHARMA is registered in France and entered in the “Sirene business register (INSEE)” under number 308197185. Its legal form is société par actions simplifiée (SAS) – simplified joint-stock company (France). According to GLEIF, its ultimate parent is IPSEN (France), which is also its direct parent. That group has 3 subsidiaries with LEIs in 1 country, 3 of them in France. It has 2 direct subsidiaries in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 18 Dec 2013 and the record was last updated on 26 Nov 2025; the next renewal is due by 18 Dec 2026. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 30 Jun 2017, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | société par actions simplifiée (SAS) simplified joint-stock company (France) |
|---|---|
| Register | Sirene business register (INSEE) · Register website |
| Registration number | 308197185 |
| Registration authority | National Institute of Statistics and Economic Studies |
| Jurisdiction | France |
| Registered address | 70 RUE BALARD, 75015 PARIS, France |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 15 Oct 1984 |
| LEI | 96950004ZQHLJ6V8PJ87 |
| LEI status | active |
| LEI first issued | 18 Dec 2013 |
| LEI record last updated | 26 Nov 2025 |
| Next LEI renewal | 18 Dec 2026 |
| Corroboration of the LEI record | fully corroborated |
Group membership
IPSEN PHARMA this entity
MAYOLY PHARMA FRANCE France
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | IPSEN | IPSEN |
| Accounting period | 1 Jan 2017 to 30 Jun 2017 | 1 Jan 2017 to 30 Jun 2017 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | supplied by the entity only |
| Accounting standard | IFRS | IFRS |
| Relationship start | 8 Dec 1998 | 8 Dec 1998 |
| Recorded at GLEIF since | 27 Oct 2017 | 27 Oct 2017 |
| Last updated | 26 Nov 2025 | 26 Nov 2025 |
| Record status | current | current |
Direct subsidiaries (2)
- IPSEN PHARMA BIOTECH France lapsed · SIGNES
- MAYOLY PHARMA FRANCE France · RUEIL-MALMAISON
History
19 Jun 2025Registered address changed
19 Jun 2025Headquarters address changed